SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (27004)12/23/1998 5:36:00 PM
From: B.D.  Respond to of 32384
 
I just want to say that I'm generally disgusted with the performance of Ligand this year. I'll continue holding for a while longer as I bought my LGNDW with the understanding that Ligand wouldn't really start making revenues until 1999.

It's just that I sure would like to get rid of it before Y2K hits (no, there is no correlation between LGNDW, Ligand, and Y2K, it's just that I'm one of those that thinks that Y2K is going to be pretty nasty for the economy and the stock market, so I'd like to be rid of LGNDW before Dec 31, 1999!).




To: Alper H.YUKSEL who wrote (27004)12/23/1998 5:38:00 PM
From: Arthur Radley  Read Replies (3) | Respond to of 32384
 
I wouldn't spend a nickel for Panretin and Ontak as I think there is no major revenue coming from these two drugs. My hopes are with Targretin. I think we are currently seeing some final year end selling in the stock as it is still well "underwater" for the year. I would like to think that we should see a bounce before/or shortly in the new year. The January effect usually lasts for about three weeks into the new year.
We Shall See!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News